Sun Pharma Advanced Research Company Limited Announces Leadership Changes

Sun Pharma Advanced Research Company Limited Announces Leadership Changes

Sun Pharma Advanced Research Company Limited Announces Leadership Changes​

Sun Pharma Advanced Research Company Limited (SPARC) announced changes to its senior management on March 27, 2026. The company’s Board of Directors accepted the resignation of Dr. Shravanti Bhowmik, Vice President of Operations Management, effective March 31, 2026. Simultaneously, the board approved the appointment of Mr. Narendra Lakkad as Head - Corporate Development and Operations Management, effective April 1, 2026.

Mr. Lakkad holds a Master's degree in Pharmacology from L.M. College of Pharmacy, Ahmedabad. He has been associated with the Sun Pharma group since 1994, previously holding positions including Senior General Manager - Business Development at Sun Pharmaceuticals Industries Ltd. and Vice President & Head - Global Business Development, Investor Relations & Corporate Communications at SPARC from 2014 to 2018. He most recently served as Vice President & Head - Program Management & Alliance Management (Specialty Portfolio) until 2023. Prior to joining SPARC, Mr. Lakkad served as Principal Advisor at the Shantilal Shanghvi Foundation, where he played a role in establishing a Comprehensive Eye Institute, a Cancer Day-care Centre and Sanatorium Facility.

ParticularsDr. Shravanti BhowmikMr. Narendra Lakkad
Reason for changeResignationAppointment
Date of cessation/appointmentClose of business hours on March 31, 2026April 01, 2026


Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top